<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03383198</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00072519</org_study_id>
    <nct_id>NCT03383198</nct_id>
  </id_info>
  <brief_title>Pectoralis (II) Block With Liposomal Bupivacaine vs Bupivacaine for Breast Surgery</brief_title>
  <official_title>Pectoralis (II) Block With Liposomal Bupivacaine vs Bupivacaine Plus Dexamethasone for Mastectomy With Immediate Reconstruction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Greenville Health System</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Greenville Health System</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized controlled pilot study evaluating length of pain control with either
      liposomal bupivacaine or with bupivacaine plus decadron after PEC II injection in patients
      having bilateral mastectomies with immediate reconstruction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This research hopes to determine the duration of patient-reported analgesia provided by
      ultrasound guided PEC II field block injections. The design of the study randomly assigns the
      side of injection of the study drugs into each patient. All patients are having bilateral
      mastectomy with immediate reconstruction. Visual analog pain scores (VAS) will be recorded
      serially for both sides of the patient's chest in hopes of determining a difference in
      duration and efficacy of the two drugs. In addition to VAS scores, a subjective, binary
      question will be our primary outcome: does one side of your chest have more surgical pain
      than the other? We hope that his question, despite being entirely subjective, overcomes
      interpatient variability of numerical pain score reporting.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2017</start_date>
  <completion_date type="Anticipated">August 30, 2018</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
    <masking_description>Only anesthesiologist performing injection will be aware of which side is injected with each drug.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Subjective bilateral pain comparison</measure>
    <time_frame>up to 48 hours</time_frame>
    <description>Subjective, binary question &quot;Does one side of your chest have more surgical pain than the other?&quot;</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of analgesia</measure>
    <time_frame>up to 48 hours</time_frame>
    <description>Duration of analgesia perception by patient measured bilaterally using Visual Analog Scale</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>Liposomal Bupivacaine Left</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Liposomal Bupivacaine left injection. Liposomal Bupivacaine is injected on the left, Bupivacaine plus Dexamethasone on the right</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Liposomal Bupivacaine Right</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Liposomal Bupivacaine right injection. Liposomal Bupivacaine injected on the right, Bupivacaine plus Dexamethasone on the left</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Liposomal bupivacaine right injection</intervention_name>
    <description>Right side will have liposomal bupivacaine ultrasound guided PEC II field block injection ; the left side side will have bupivacaine plus dexamethasone ultrasound guided PEC II field block injection.</description>
    <arm_group_label>Liposomal Bupivacaine Right</arm_group_label>
    <other_name>Exparel Right</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Liposomal bupivacaine left injection</intervention_name>
    <description>Left side will have liposomal bupivacaine ultrasound guided PEC II field block injection ; the right side side will have bupivacaine plus dexamethasone ultrasound guided PEC II field block injection.</description>
    <arm_group_label>Liposomal Bupivacaine Left</arm_group_label>
    <other_name>Exparel Left</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Scheduled for bilateral mastectomy

        Exclusion Criteria:

          -  allergy to local anesthetics, prior breast surgery, asymmetric surgical plan
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Bilateral mastectomy</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>William Hand, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Greenville Health System</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>William Hand, MD</last_name>
    <phone>(864) 522-3707</phone>
    <email>whand@ghs.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Patewood Memorial Hospital</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29615</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>William Hand, MD</last_name>
    </contact>
    <investigator>
      <last_name>William Hand, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Bashandy GM, Abbas DN. Pectoral nerves I and II blocks in multimodal analgesia for breast cancer surgery: a randomized clinical trial. Reg Anesth Pain Med. 2015 Jan-Feb;40(1):68-74. doi: 10.1097/AAP.0000000000000163.</citation>
    <PMID>25376971</PMID>
  </reference>
  <reference>
    <citation>Amundson AW, Johnson RL, Abdel MP, Mantilla CB, Panchamia JK, Taunton MJ, Kralovec ME, Hebl JR, Schroeder DR, Pagnano MW, Kopp SL. A Three-arm Randomized Clinical Trial Comparing Continuous Femoral Plus Single-injection Sciatic Peripheral Nerve Blocks versus Periarticular Injection with Ropivacaine or Liposomal Bupivacaine for Patients Undergoing Total Knee Arthroplasty. Anesthesiology. 2017 Jun;126(6):1139-1150. doi: 10.1097/ALN.0000000000001586.</citation>
    <PMID>28234636</PMID>
  </reference>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 19, 2017</study_first_submitted>
  <study_first_submitted_qc>December 19, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 26, 2017</study_first_posted>
  <last_update_submitted>January 10, 2018</last_update_submitted>
  <last_update_submitted_qc>January 10, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

